Agence de la biomédecine - AMP Vigilance, 2024
Abstract
Rapport annuel d'AMP Vigilance 2023 de l'Agence de la biomédecine. ENGLISH
Summary
2023 ART vigilance report from the French Agence de la biomédecine. AMP Vigilance is the mandatory adverse-event surveillance system covering serious adverse events and reactions related to assisted reproduction practice in France. Reports cycle counts, vigilance signals, and incident classifications across French ART centers.